The Gold Standard In Dietary Supplement Certification
BSCG Certified Drug Free

Home > First Reporting A Form Of Epo Darbepoetin Alfa In Sport

sidebar-contact-img

Certified Drug Free®

Search According to Lot Number

Subscription to News and Blog

FIRST REPORTING A FORM OF EPO (DARBEPOETIN ALFA) IN SPORT

DR. CATLIN FIRST REPORTED THE USE OF A FORM OF EPO (DARBEPOETIN ALFA) IN SPORT

While overseeing the drug testing at the 2002 Winter Olympic Games in Salt Lake City, Dr. Catlin revealed the use of a form of EPO, or erythropoietin, (darbepoetin alfa), for the first time in sport. He used a new test developed by French scientist Dr. Françoise Lasne to detect this long-lasting form of EPO, a then newly approved drug for anemia patients that helps boost red blood cells and aids in endurance but can lead to serious health outcomes such as heart attack and stroke. Three Olympic cross-country skiers, including gold medalists Larissa Lazutina of Russia and Johann Muehlegg of Spain, were suspended and their medals stripped after they were found using the substance in Olympic competition.

More Info

For a thorough introductory account of the story, read the book “The Night Olympic Team,” written for older kids by Caroline Hatton, Ph.D., one of the scientists working in the Olympic lab under Dr. Catlin.

Academic Publication

Catlin DH, Breidbach A, Elliott S, Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine. Clinical Chemistry 2002. 48: 2057-9. Full Text PDF

BSCG CERTIFIED CLIENTS

Twitter

facebook

The Catlin Perspective

Address
11301 W. Olympic Blvd. Suite 685 Los Angeles, CA 90064

Marketing E-mail
info@bscg.org